ClinicalTrials.Veeva

Menu

The Effect of Midazolam on Fluid Responsiveness in Septic Patients

S

Southeast University, China

Status and phase

Completed
Phase 2
Phase 1

Conditions

Septic Shock

Treatments

Drug: sedatives(Midazolam and Propofol)

Study type

Interventional

Funder types

Other

Identifiers

NCT02050893
fluid responsiveness

Details and patient eligibility

About

Fluid resuscitation remains the foundation for septic treatment.The evaluation of fluid responsiveness has significance in volume resuscitation for septic shock patients. As the sedative which is commonly used in ICU, Midazolam is supposed to change fluid responsiveness for the pharmacological effect of venodilation. However, the hypothesis has not been certified clinically. In this research, the investigators aim to test the hypothesis that Midazolam can increase fluid responsiveness(using passive leg raising test) in septic shock patients.

Enrollment

40 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Patients are included if they meet the following inclusion criteria:

  1. Above 18 years old
  2. Endotracheal intubated and mechanical ventilated
  3. Awake, can communicate with researchers
  4. Diagnosed as septic shock. The definition of septic shock was clarified in Year 2001 ACCP/SCCM guidelines
  5. Within 24 hours after the EGDT resuscitation goals are achieved
  6. Informed consent are signed.

Exclusion Criteria

  1. Under 18 years old
  2. Intra-abdominal hypertension
  3. Central nerves system dysfunction
  4. Heart failure and other cardiac dysfunction such as cardiac conduction block,acute coronary syndrome, cardiogenic shock
  5. Proof of volume overload or contradiction of fluid infusion
  6. Existence of arterial aneurysm, serious valvular disease,extensive peripheral vascular occlusion disease and insertion of artificial pacemaker

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

Midazolam
Experimental group
Description:
Midazolam infused at a 0.03mg/kg loading dose ,and 0.02-0.1mg/kg.h maintenance dose to achieve Ramsay score of 4
Treatment:
Drug: sedatives(Midazolam and Propofol)
Propofol
Experimental group
Description:
Propofol infuse at a loading dose of 0.5mg/kg,and 0.5-2.0mg/kg.h maintenance dose to achieve Ramsay score of 4
Treatment:
Drug: sedatives(Midazolam and Propofol)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems